US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.870
  • -0.090-2.27%
Close Nov 4 16:00 ET
  • 3.824
  • -0.047-1.20%
Post 20:02 ET
730.59MMarket Cap-8600P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
1.90M
-59.46%
EPS
-0.10
+20.78%
Analyst Rating
Buy

Nov 2, 2024

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.696M--
Nov 6, 20242024/Q3-- / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.696M--
Nov 6, 20242024/Q3-- / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

  • Arbutus Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 9 04:53

  • Arbutus Biopharma | 10-Q: Q1 2024 Earnings Report

    May 3 04:40

  • Arbutus Biopharma | 10-K: FY2023 Annual Report

    Mar 6 05:54

  • Arbutus Biopharma | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 05:18

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 2, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data